Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Healthcare Diagnostics & Research

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc > P.Placement at .22cents share price at .54 !!!!

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 09, 2021 9:18am

115 Views

Post# 32511075

RE:P.Placement at .22cents share price at .54 !!!!

Co.s reserve a price with TSXV before doing a PP so there is a lag effect.....

StockDoc60 wrote:
This is very unusual . At today's price, private placement is only 40% of share price !!!

Furthermore there is no news to act as a catalyst for recent share price activity. Given that there will be about 20% dilution with the extra shares and warrants valuation would normally decline somewhat ,at least in the short term .

Liking the green in my account but something doesn't add up !

Maybe it's simply the redditt phenomenon on a small scale ?..